Policy & Regulation
ReViral, LianBio Ink Collaboration and License Agreement to Develop and Commercialize Sisunatovir in China
3 March 2021 - - UK-based biopharmaceutical company ReViral Ltd and China-based biotechnology company LianBio have inked an exclusive collaboration and license agreement for the development and commer...
US FDA Accepts Eyenovia's MydCombi NDA
3 March 2021 - - The US Food and Drug Administration has accepted US-based clinical stage ophthalmic biopharmaceutical company Eyenovia, Inc's (NASDAQ: EYEN) New Drug Application for MydComb...
VeriSIM Life Secures a Federal Grant to Create a Drug Combinatorial Platform Against COVID-19
3 March 2021 - - US-based preclinical and clinical drug development company VeriSIM Life has been awarded a National Science Foundation Small Business Innovation Research grant for ...
FDA Approves Investigational New Drug for Neuroendocrine Tumors from Molecular Targeting Technologies
3 March 2021 - - US-based clinical stage radiopharmaceutical therapy company Molecular Targeting Technologies, Inc's Investigational New Drug application has been approved by the US Food and Drug...
Akoya, Johns Hopkins' Collaborative Agreement Supports Pioneering New Approach to Immunotherapy Biomarker Discovery and Validation
3 March 2021 - - US-based biotechnology company Akoya Biosciences, Inc has forged a collaboration with the Bloomberg-Kimmel Institute for Cancer Immunotherapy and the Bloomberg Center for Physics and ...
VeriSIM Life Secures a Federal Grant to Create a Drug Combinatorial Platform Against COVID-19
3 March 2021 - - US-based preclinical and clinical drug development company VeriSIM Life has been awarded a National Science Foundation Small Business Innovation Research grant for ...